Novartis AG
Dosage Regimens For Anti-Pd-L1 Antibodies And Uses Thereof

Abstract:

Antibody molecules that specifically bind to PD-L1 are disclosed. Combination therapies comprising the anti-PD-L1 antibody molecules are also disclosed. The anti-PD-L1 antibody molecules can be used to treat, prevent and/or diagnose cancerous or infectious conditions and disorders.